262 related articles for article (PubMed ID: 34523148)
1. Neuroprotective potential of berberine in modulating Alzheimer's disease via multiple signaling pathways.
Akbar M; Shabbir A; Rehman K; Akash MSH; Shah MA
J Food Biochem; 2021 Oct; 45(10):e13936. PubMed ID: 34523148
[TBL] [Abstract][Full Text] [Related]
2. Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer's disease.
Singh AK; Singh SK; Nandi MK; Mishra G; Maurya A; Rai A; Rai GK; Awasthi R; Sharma B; Kulkarni GT
Cent Nerv Syst Agents Med Chem; 2019; 19(3):154-170. PubMed ID: 31429696
[TBL] [Abstract][Full Text] [Related]
3. Berberine derivatives as inhibitors of acetylcholinesterase: A systematic review.
Singh YP; Kumar H
Chem Biol Drug Des; 2023 Dec; 102(6):1592-1603. PubMed ID: 37665093
[TBL] [Abstract][Full Text] [Related]
4. Role of berberine in Alzheimer's disease.
Cai Z; Wang C; Yang W
Neuropsychiatr Dis Treat; 2016; 12():2509-2520. PubMed ID: 27757035
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of berberine in animal models of Alzheimer's disease: a systematic review of pre-clinical studies.
Yuan NN; Cai CZ; Wu MY; Su HX; Li M; Lu JH
BMC Complement Altern Med; 2019 May; 19(1):109. PubMed ID: 31122236
[TBL] [Abstract][Full Text] [Related]
6. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
[TBL] [Abstract][Full Text] [Related]
7. Berberine Improves Behavioral and Cognitive Deficits in a Mouse Model of Alzheimer's Disease via Regulation of β-Amyloid Production and Endoplasmic Reticulum Stress.
Liang Y; Ye C; Chen Y; Chen Y; Diao S; Huang M
ACS Chem Neurosci; 2021 Jun; 12(11):1894-1904. PubMed ID: 33983710
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of berberine against environmental heavy metals-induced neurotoxicity and Alzheimer's-like disease in rats.
Hussien HM; Abd-Elmegied A; Ghareeb DA; Hafez HS; Ahmed HEA; El-Moneam NA
Food Chem Toxicol; 2018 Jan; 111():432-444. PubMed ID: 29170048
[TBL] [Abstract][Full Text] [Related]
9. Screening of Synthetic Isoxazolone Derivative Role in Alzheimer's Disease: Computational and Pharmacological Approach.
Ali M; Saleem U; Anwar F; Imran M; Nadeem H; Ahmad B; Ali T; Atta-Ur-Rehman ; Ismail T
Neurochem Res; 2021 Apr; 46(4):905-920. PubMed ID: 33486698
[TBL] [Abstract][Full Text] [Related]
10. Modulation of LOX and COX pathways via inhibition of amyloidogenesis contributes to mitoprotection against β-amyloid oligomer-induced toxicity in an animal model of Alzheimer's disease in rats.
Kalra J; Kumar P; Majeed AB; Prakash A
Pharmacol Biochem Behav; 2016; 146-147():1-12. PubMed ID: 27106205
[TBL] [Abstract][Full Text] [Related]
11. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
[TBL] [Abstract][Full Text] [Related]
12. Berberine mitigates cognitive decline in an Alzheimer's Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance.
Chen Y; Chen Y; Liang Y; Chen H; Ji X; Huang M
Biomed Pharmacother; 2020 Jan; 121():109670. PubMed ID: 31810131
[TBL] [Abstract][Full Text] [Related]
13. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer's disease: a systematic review and meta-analysis.
Dan L; Hao Y; Li J; Wang T; Zhao W; Wang H; Qiao L; Xie P
Front Pharmacol; 2023; 14():1287750. PubMed ID: 38259291
[No Abstract] [Full Text] [Related]
15. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
16. A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease.
Singh YP; Rai H; Singh G; Singh GK; Mishra S; Kumar S; Srikrishna S; Modi G
Eur J Med Chem; 2021 Apr; 215():113278. PubMed ID: 33662757
[TBL] [Abstract][Full Text] [Related]
17. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Cai Z; Wang C; He W; Chen Y
Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
[TBL] [Abstract][Full Text] [Related]
18. Functional effects of berberine in modulating mitochondrial dysfunction and inflammatory response in the respective amyloidogenic cells and activated microglial cells - In vitro models simulating Alzheimer's disease pathology.
Wong LR; Tan EA; Lim MEJ; Shen W; Lian XL; Wang Y; Chen L; Ho PC
Life Sci; 2021 Oct; 282():119824. PubMed ID: 34265361
[TBL] [Abstract][Full Text] [Related]
19. Association between chronic stress and Alzheimer's disease: Therapeutic effects of Saffron.
Saeedi M; Rashidy-Pour A
Biomed Pharmacother; 2021 Jan; 133():110995. PubMed ID: 33232931
[TBL] [Abstract][Full Text] [Related]
20. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
